Showing results (1-10 of 323) with videos related to

Sort By:
Pageof 33
Journal of Hypertension|July 11, 2020
Chronic kidney disease as a cardiovascular risk factorRafael Carmena, Juan F Ascaso, Josep Redon
Blood Pressure|March 6, 2024
Present and future of drug therapy in hypertension: an overviewJosep Redon, Rafael Carmena
Medicina Clinica|January 5, 2010
[Global therapy of diabetic dyslipidemia: benefits and new therapeutic approaches]Rafael Carmena, Juan F Ascaso
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 14, 2015
[Importance of dyslipidaemia in cardiovascular disease: a point of view]Juan F Ascaso, Rafael Carmena
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 18, 2023
Cardiovascular prevention in diabetes mellitus. Is it appropriate to speak of moderate or intermediate risk?Sergio Martínez-Hervás, José T Real, Rafael Carmena, et al.
Metabolism: Clinical and Experimental|October 6, 2009
Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemiaJose T Real, Sergio Martínez-Hervás, M Carmen Tormos, et al.
Medicina Clinica|September 22, 2006
[Role of atherogenic dyslipidemia in the development of metabolic syndrome]José T Real, Pedro Romero, Sergio Martínez Hervas, et al.
Diabetes Care|November 25, 2003
Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolismJuan F Ascaso, Susana Pardo, José T Real, et al.
European Journal of Internal Medicine|April 30, 2003
Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European populationJuan F Ascaso, Pedro Romero, José T Real, et al.
Pageof 33